Keyphrases
B Cells
87%
Childhood Acute Lymphoblastic Leukemia
58%
Complement Receptors
58%
Erythrocytes
46%
Minimal Residual Disease
43%
Acute Lymphoblastic Leukemia
42%
High Risk
39%
B Lymphocytes
38%
CD21
33%
Cerebrospinal Fluid
33%
Flow Cytometry
32%
Cytospin
29%
Monocytes
29%
Hazard Ratio
29%
Whole Blood Cells
29%
Irradiation Treatment
29%
Multiple Sclerosis
29%
Thymoma
29%
Consolidation Treatment
29%
Relapse Risk
29%
Leukemic Blast
29%
Membrane Attack Complex
29%
Relapsing-remitting multiple Sclerosis
29%
Lymphocytopenia
29%
Systemic Lupus Erythematosus
29%
Human B Cells
29%
Myositis
29%
Receptor Subtypes
29%
TGF-1
29%
Receptor Expression
29%
Cell-based
29%
Hematopoietic Cell Transplantation
29%
Treatment Strategy
29%
Lymphomagenesis
29%
Lymphocytes
29%
Complex Formation
29%
Klinefelter Syndrome
29%
Tumor Suppressor
29%
Pediatric Oncology
29%
PR Domain
29%
Randomized Controlled Trial
29%
IL-12 Receptor
29%
Leukemia
29%
Cooperative Study
29%
Overexpression
29%
Complement Cascade
29%
Receptor Activation
29%
Oncogene
29%
6-mercaptopurine (6-MP)
29%
Leukocyte Subsets
29%
Immunology and Microbiology
B Cell
65%
Leukocyte
58%
Complement Receptor 2
45%
Erythrocyte
32%
Muscle
29%
Otitis Media
29%
Gene Rearrangement
29%
Cell Transplantation
29%
Complement Membrane Attack Complex
29%
Mycobacteria
29%
Leukocyte Count
29%
Alternative Complement Pathway
29%
Hematopoietic Stem Cell Transplantation
29%
Griscelli Syndrome
29%
Hemophagocytic Lymphohistiocytosis
29%
Arm
29%
Immunoglobulin A Deficiency
29%
Properdin
29%
Relapsing Remitting Multiple Sclerosis
29%
Hematopoietic Cell
29%
Chimera
29%
Granulocyte
29%
Complex Formation
29%
High Risk Population
29%
Immune Complex
29%
Complement Receptor 1
29%
Multiple Sclerosis
29%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
46%
High Risk Population
29%
Hazard Ratio
29%
Acute Lymphocytic Leukemia
29%
Cell Transplantation
29%
Mercaptopurine
29%
Hemophagocytic Syndrome
29%
Myositis
29%
Pediatric Oncology
29%
Pediatric Hematology
29%
Hematopoietic Cell
29%
Leukemia
29%
Cerebrospinal Fluid
29%
Griscelli Syndrome
29%
Leukocyte
29%
Thymus Cancer
29%
Arm
29%
Randomized Controlled Trial
29%
Pediatrics
21%
Immunophenotyping
21%
Central Nervous System
19%
Flow Cytometry
19%
Cell Count
19%
Risk Stratification
19%